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Introduction
Spinal anesthesia with bupivacaine is traditionally used in 
combination with opioids for emergency and elective cesarean 
section, and provides satisfactory outcomes. However, this strat-
egy is associated with a significant incidence of hypotension re-
sulting from sympathetic blockade [1-3]. Maternal hypotension 
jeopardizes placental perfusion, compromises fetal outcome, 
and can cause symptoms such as nausea, vomiting, and dizzi-
ness [4,5]. Many spinal anesthesia dosing regimes have been 
described for cesarean section [6]; while a fixed dosing regimen 
is preferred by some anesthetists, others adjust the dose based 
 Clinical Research Article
Background: Spinal anesthesia with bupivacaine, typically used for elective and emergency cesarean section, is associ-
ated with a significant incidence of hypotension resulting from sympathetic blockade. A variety of dosing regimens have 
been used to administer spinal anesthesia for cesarean section. The objective of this study was to compare the incidence 
of hypotension following two different fixed dosing regimens. 
Methods: This was a randomized double-blind clinical trial with a two-sided design, 5% significance level and 80% 
power. After approval of the hospital ethics review committee, 60 patients were divided randomly into two groups. In one 
group, the local anesthetic dose was adjusted according to height and weight, and in the other, the dose was adjusted ac-
cording to height only. 
Results: Sixty women with a singleton pregnancy were included. Of the factors that could affect dose and blood pressure, 
including age, weight, height, and dose, only height differed between the groups. Mean heart rate was similar between the 
groups. Hypotension was significantly more frequent with dosage based on height alone than with two-factor dose calcu-
lation (56.7% vs. 26.7%; P = 0.018).
Conclusions: Adjusting the dose of isobaric bupivacaine to a patient’s height and weight provides adequate anesthesia for 
elective cesarean section and is associated with a decreased incidence and severity of maternal hypotension and less use 
of ephedrine.
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on patient characteristics. Adjusted dosing is supported by he-
modynamic data showing that the time to attain a suitable sen-
sory level for surgery correlates incrementally with height and is 
inversely related to weight [7]. 
Previous studies have confirmed that the final level of the 
block can be predicted by patient height and weight [8]. The op-
timal dose would allow dermatomal spread but avoid maternal 
hypotension. In some studies, local anesthetic dose has been 
adjusted with height alone [9]. However, whether height of the 
block is related to patient height and weight or height only is 
controversial. The purpose of this study was to determine the 
best dosing regimen for adequate anesthesia with minimal side 
effects.
Materials and Methods
This study was approved by the Ethics Review Committee 
of Aga Khan University, and written informed consent was ob-
tained from all patients included in the study. Sixty women with 
singleton pregnancies and American Society of Anesthesiologists 
physical status classifications I and II who were scheduled for 
elective cesarean section were included. Women with a history 
of pregnancy-induced hypertension, cardiovascular co-morbid-
ities, known central nervous system disease, contraindications 
to neuraxial block, weight < 50 kg or > 110 kg, height > 180 
cm or < 140 cm, and allergy to local anesthetics were excluded. 
Patients were randomized to the two groups using computer-
generated codes sequentially allocated to sealed envelopes. 
In the first patient group, the local anesthetic dose was ad-
justed according to height and weight (Table 1), whereas those 
in the other group received a local anesthetic dose adjusted ac-
cording to height only (Table 2). Patients were premedicated 
with intravenous 50 mg ranitidine, 10 mg metoclopramide, and 
30 ml oral sodium citrate 30 min before surgery.
Patients and researchers were blinded to group allocations. 
The anesthetist who administered the neuraxial block was 
unblinded. The drugs for each group were prepared in 3 ml sy-
ringes.
Our routine perioperative monitoring included continu-
ous SpO2, electrocardiograph, and noninvasive blood pressure 
monitoring. Hemodynamic variables were monitored every 5 
min during surgery after spinal anesthesia was induced (Datex 
Ohmeda AS, Helsinki, Finland). The level of sensory block was 
assessed 5 min after administering the spinal anesthetic.
After infiltrating the skin with 2% lidocaine, intravenous 
access was obtained with an 18 G or 16 G wide bore cannula 
through which all patients were preloaded with a balanced crys-
talloid solution (10 ml/kg) over 10 min before inducing spinal 
anesthesia. Aseptic measures were used when administering 
drugs into the spine. Subarachnoid block was obtained with the 
patient in the sitting position using a 25 G pencil point spinal 
needle at the L2–3 vertebral inter space. After aspirating cere-
brospinal fluid, patients in the first group received 25 µg fentanyl 
(0.5 ml) in isobaric 0.5% bupivacaine determined according 
to the dosing regimen described in Table 1, while those in the 
other group received the same drug solution at 0.05 mg/cm (Ta-
ble 2) over 5 seconds. Patients were immediately turned supine 
and maintained in the wedge position to minimize aortocaval 
compression. Supplemental oxygen at 4 L/min was given to all 
patients via face mask. 
The usual hemodynamic alterations after administration of 
spinal anesthesia as described in the literature were anticipated 
and considered, such as bradycardia, hypotension, nausea/
vomiting, and ineffective spinal anesthesia. Bradycardia (heart 
rate < 60 /min) was treated with intravenous 0.5 mg atropine, 
hypotension (> 20% decrease in baseline mean arterial pressure 
[MAP] and heart rate) and nausea, vomiting or dizziness were 
treated with intravenous 5 mg ephedrine.
Table 1. Weight- and Height-adjusted 0.5% Bupivacaine Dosing Regimen 
for Spinal Anesthesia in Women Undergoing cesarean Section 
Patient 
weight (kg)
Patient height (cm)
140 145 150 155 160 165 170 175 180
50 1.5 1.7 1.8 1.9
55 1.5 1.6 1.8 1.9 2.0
60 1.4 1.6 1.7 1.8 2.0 2.1
65 1.4 1.5 1.7 1.8 1.9 2.1 2.2
70 1.3 1.5 1.6 1.8 1.9 2.0 2.2 2.3
75 1.4 1.6 1.7 1.9 2.0 2.1 2.3 2.4
80 1.4 1.5 1.7 1.8 2.0 2.1 2.2 2.4
85 1.5 1.6 1.8 1.9 2.1 2.2 2.3
90 1.4 1.6 1.7 1.9 2.0 2.2 2.3
95 1.5 1.7 1.8 2.0 2.1 2.3
100 1.5 1.7 1.8 1.9 2.1 2.2
105 1.6 1.7 1.9 2.0 2.2
110 1.7 1.8 2.0 2.2
Values are milliliters.
Table 2. Bupivacaine Dose and Volume with Respect to Patient Height
Patient height (cm) Dose (mg) Dose (ml)
140 7.0 1.4
145 7.2 1.4
150 7.5 1.5
155 7.7 1.5
160 8.0 1.6
165 8.2 1.6
170 8.5 1.7
175 8.7 1.7
180 9.0 1.8
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Once the sensory block was determined to be effective, sur-
gery was initiated when loss of cold and pinprick sensations in 
response to ethyl chloride spray were observed bilaterally. A 10o 
head-down tilt was employed to improve block height and ad-
dress ineffective blockade as evaluated at 8 min. A mixture of 
50 : 50 O2 : N2O was administered by face mask if discomfort 
was reported by the patient during surgery. If discomfort per-
sisted, two intravenous boluses of 50 µg fentanyl were adminis-
tered. We converted to general anesthesia if these measures were 
inadequate. 
Sixty subjects (30 /group) needed to be included in the study 
to achieve 80% power at a 5% level of significance to detect a 
25% difference in the incidence of hypotension between groups. 
The incidence of hypotension in two pilot study groups were 
34% and 9%. All statistical analyses were performed using SPSS 
version 19.0 (IBM Corp., Armonk, NY, USA). Means or medi-
ans and frequency/percentage were computed for quantitative 
and qualitative observations, respectively. Quantitative variables 
were compared by Mann–Whitney U-test and independent 
samples t-test, while proportions were compared by chi-square 
test, and median time to adequate spinal block was compared 
using the median test. Changes in heart rate and MAP were de-
tected using repeated-measures analysis of variance. A P value ≤ 
0.05 was considered significant.
Results
Sixty women with singleton pregnancies were analyzed. 
Patients’ mean age was 29.50 ± 7.90 years (95% confidence in-
terval [CI], 27.46–31.54), and mean weight and height were .86 
± 11.98 kg (95% CI, 70.76–76.96) and 157 ± 6.286 cm (95% CI, 
156.03−159.27), respectively. Age, weight, and spinal anesthetic 
dose did not differ between the groups, but mean height did 
(P = 0.027) (Table 3).
The comparison of height and time to adequate spinal block 
between the groups is shown in Table 4. The block was per-
formed at T4 in 24 patients (80%) in the group whose anesthe-
sia was dosed based on height and weight and in 27 (90%) in 
the group with dosages based on height alone. Median time to 
achieve adequate block in the first group was significantly longer 
than that for the second group (P = 0.005). However, block level 
did not differ between groups. 
Mean heart rate did not differ between groups but a significant 
within-group difference was detected in mean heart rate (P < 0.05). 
MAP was similar between groups up to 30 min; however, a sig-
nificant within-group difference was observed (P = 0.05; Figs. 1 
and 2). 
Bradycardia occurred in one patient receiving an anesthesia 
dose based on both factors. The incidence of hypotension was 
significantly higher in the height-alone dosage group than in the 
two-factor dosage group (56.7% vs. 26.7%; P = 0.018). More pa-
tients receiving height-calculated anesthesia were given ephedrine 
than in the other group (53.3% vs. 30.6%, P = 0.02), and a large 
median dose was administered (10.5 mg vs. 7.5 mg, P = 0.042).
Four patients with two-factor anesthesia dosage had episodes 
of vomiting, whereas three such cases were observed in the oth-
er group (Fig. 3). None of the patients were converted to general 
anesthesia due to inadequate subarachnoid block.
Mean time to effective block (min) did not differ between 
the groups (Table 5). Patients receiving two-factor anesthesia 
dosages tended to take a longer time to be discharged from the 
recovery room than those in the other group. No differences in 
Table 3. Patient Demographic Data 
Variables Height/weight dosing(n = 30)
Height-only dosing
(n = 30) P value
Age (yr) 29.26 ± 8.84 29.73 ± 6.99 0.52
Weight (kg) 72.4 ± 12.65 75.31 ± 11.31 0.35
Height (cm) 159.4 ± 5.73
159.5 [7]
155.86 ± 6.40
157 [9]
0.027*
0.05†
Dose 8.39 ± 0.81 8.29 ± 2.00 0.45
Values are mean ± standard deviation and median [interquartile range]. 
*Significant at P < 0.05 by independent sample t-test. †Mann–Whitney 
U-test.
Table 4. Comparison of Height and Time to Adequate Block between the Groups
Height of block*
Height/weight dosing
(n = 30)
Height-only dosing
(n = 30) Total
n (%) Median time in minutes (IQR) n (%) Median time in minutes (IQR)
T3 0 (0%) - 1 (3.3%) - 1 (1.7%)
T4 24 (80%) 8 [6] 27 (90%) 5 [4] 51 (85%)
T5 4 (13.3%) 8 [53] 1 (3.3%) - 5 (8.3%)
T6 2 (6.7%) 11 [0] 0 (0%) - 2 (3.3%)
T10 0 (%) - 1 (%) - 1 (1.7%)
Time to adequate block - 8 [5] - 5 [4] 0.005
Values are numbers (%) and medians [interquartile range]. *P = 0.472, Fisher’s exact test; and P < 0.01; median test applied.
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the 1 and 5 min fetal APGAR scores were observed between the 
groups.
Discussion
Spinal anesthesia is generally used during cesarean sections 
because it keeps the mother conscious, decreases problems relat-
ed to complex intubation and maternal aspiration pneumonitis, 
and facilitates effective postoperative pain relief. However, spinal 
anesthesia can cause hypotension [10,11], which leads to in 
utero placental hypoperfusion and instigates a severe drop in in-
tervillous blood flow with the possibility of fetal acidemia [12,13]. 
A wide range of spinal anesthesia dosing regimes has been used 
during cesarean section [6]. A direct correlation with height and 
an inverse correlation with weight have been suggested based 
on pharmacodynamic data collected at the time to onset of an 
adequate sensory level for surgery and has been validated by 
clinical observations [14].
In this prospective, double-blind, randomized study, we com-
pared two spinal anesthesia dosing regimes for cesarean section 
based on either patient height plus weight or height alone. The 
onset time for suitable sensory blockade was longer in the height 
plus weight group, although it was associated with decreased 
prevalence and acuteness of maternal hypotension and a lower 
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Fig. 1. Comparison of mean heart rate between patients receiving 
anesthesia dosages based on height and weight (n = 30, triangles, solid 
line) and those whose dose was calculated based on height alone (n = 
30, circles, dotted line). Error bars are 95% confidence intervals. No 
difference was observed between groups but a significant difference was 
observed from baseline *P < 0.05 in the height-weight group and †P < 0.05 
in the height-alone group.
60
M
A
P
(m
m
H
g
)
Time (min)
25
90
85
80
75
70
65
7 10 15 20BL 1 4 30
*,
*, *,
*, *,
*,
*, *,
Fig. 2. Comparison of mean arterial pressure (MAP) between patients 
receiving anesthesia dosages based on height and weight (n = 30, 
triangles, solid line) and those whose dose was calculated based on 
height alone (n = 30, circles, dotted line). Error bars are 95% confidence 
intervals. No difference was observed between the groups but a 
significant difference was observed from baseline *P < 0.05 in the 
height-weight group and †P < 0.05 in the height-alone group.
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Fig. 3. Comparison of complications between the groups.
Table 5. Comparisons of Hypotension Treatment, Time to Reverse Block, and Discharge from the Recovery Room
Height/weight dosing
(n = 30)
Height-only dosing
(n = 30) P value
Hypotension treated with‡
    Ephedrine 8 (26.7%) 16 (53.3%) 0.03*
    Fentanyl 5 (16.7%) 2 (6.7%) 0.22
    N2O 2 (6.7%) 0 (0%) 0.49
Time to block reversal (min)† 115 [21] 110 [11] 0.081
Time to discharge from recovery room (min)† 130 [21] 125 [11] 0.084
Values are numbers (%) and medians [interquartile range]. *P < 0.05. †Mann–Whitney U-test. ‡Chi-square test.
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ephedrine requirement. This group tended to spend more time 
in the recovery room before discharge than the other group but 
the difference was not statistically significant. Norris [14] reported 
that height has no effect on hyperbaric spinal anesthesia. How-
ever, theoretically, hypotension severity should be affected by 
the quantity and volume of local anesthetic agent used. Harten 
et al. [15] reported that the incidence and severity of maternal 
hypotension decrease after adjusting the dose of hyperbaric bu-
pivacaine to the patient’s height and weight, which is comparable 
with our results. 
In contrast to other studies, Nagata et al. [16] of Japan and 
Chung et al. [2] of Korea demonstrated that pregnant women 
require less local anesthetic compared to their nonpregnant 
counterparts and that a height-adjusted dosing regime avoids 
the risk of maternal hypotension. However, height-based dosing 
was not compared with that based on height plus weight in these 
studies.
Our results suggest that adjusting the anesthetic dose to 
height and weight improves the safety of spinal anesthesia. Al-
though the incidence and acuteness of maternal hypotension 
declined in the height and weight group, its association with 
improved fetal outcome was not verified. 
In addition, variables affecting the spread and duration of 
regional anesthesia, including but not limited to basicity, total 
dose, type of local anesthetic solution, injection site, and patient 
positioning must be considered, as they may affect the final out-
come. Although spinal anesthesia is effective and safe, all cor-
roborative factors should be considered.
The highest incidence of hypotension in women undergo-
ing cesarean section is observed under spinal anesthesia. Non-
modifiable risk factors include female sex, age > 50 years, body 
mass index > 35 kg/m2, and the nature of the surgery. Two other 
modifiable risk factors are high bupivacaine dose and a sensory 
block level ≥ T5 [17]. In this study, all variables were compa-
rable, except patient height.
Anesthesia may need to be augmented with intravenous nar-
cotics if sensory block is insufficient or if the surgeon encounters 
an unexpected event that requires more time, increasing anes-
thesia duration. Many studies have shown that various additives, 
such as morphine and fentanyl enhance the spread and dura-
tion of spinal block via multiple administration routes [18]. We 
found no difference in the use of fentanyl between according to 
anesthesia dosage calculation method.
The incidence of hypotension during spinal anesthesia for 
cesarean section is as high as 80% despite fluid preloading, lat-
eral uterine displacement, and use of vasopressor agents [19]. 
Preventing and managing hypotension related to spinal anes-
thesia remains a difficult issue, and no single approach is opti-
mal. Intravenous ephedrine during spinal anesthesia in women 
undergoing cesarean section decreases the incidence of nausea 
and vomiting [20]. Current local obstetric anesthesia practices 
are established on a fixed dose of bupivacaine for subarachnoid 
block without narcotics, except at some urban hospitals where 
fentanyl is available and perioperative hypotension and brady-
cardia are common. The deleterious effects of spinal anesthesia 
during cesarean section are more profound when the spinal an-
esthesia dose is not calculated logically. In this study, less ephed-
rine was used when the spinal bupivacaine dose was calculated 
in relation to patient height and weight, which decreased the 
incidence of hypotension, nausea, and vomiting.
Thus, we conclude that the isobaric 0.5% bupivacaine dosing 
regimen should be based on patient height and weight and that 
25 µg fentanyl should be added to achieve adequate anesthesia 
for cesarean sections while minimizing the untoward side effects 
of maternal hypotension with reduced use of vasopressors. 
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